These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45 related articles for article (PubMed ID: 8001410)
1. [The effects of the cyclopentyl ethinyl estriol on the cardiovascular function of postmenopausal women]. Chang C; Zhu GZ; Zhang XY Zhonghua Fu Chan Ke Za Zhi; 1994 Jun; 29(6):350-1, 382-3. PubMed ID: 8001410 [TBL] [Abstract][Full Text] [Related]
2. Nondipping status does not attenuate the conjugated estrogen-induced improvement in aortic stiffness in postmenopausal women with untreated hypertension. Tsioufis C; Tzioumis K; Dimitriadis K; Chatzis D; Skiadas I; Michailidis A; Toutouzas P; Kallikazaros I; Stefanadis C Am J Hypertens; 2005 May; 18(5 Pt 1):607-11. PubMed ID: 15882542 [TBL] [Abstract][Full Text] [Related]
3. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women. Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213 [TBL] [Abstract][Full Text] [Related]
4. The effects of sublingual estradiol on left ventricular function at rest and exercise in postmenopausal women: an echocardiographic assessment. Pines A; Fisman EZ; Drory Y; Shapira I; Averbuch M; Eckstein N; Motro M; Levo Y; Ayalon D Menopause; 1998; 5(2):79-85. PubMed ID: 9689200 [TBL] [Abstract][Full Text] [Related]
5. B-type natriuretic peptide after hormone therapy in postmenopausal women with chest pain and normal coronary angiogram. Kawano H; Nagayoshi Y; Soejima H; Tanaka Y; Hokamaki J; Miyamoto S; Miyazaki Y; Yamabe H; Ogawa H Menopause; 2008; 15(2):352-6. PubMed ID: 18090872 [TBL] [Abstract][Full Text] [Related]
6. A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome. Chu MC; Cosper P; Nakhuda GS; Lobo RA Fertil Steril; 2006 Dec; 86(6):1669-75. PubMed ID: 17074346 [TBL] [Abstract][Full Text] [Related]
7. Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women. Maffei S; Del Ry S; Prontera C; Clerico A Clin Sci (Lond); 2001 Nov; 101(5):447-53. PubMed ID: 11672449 [TBL] [Abstract][Full Text] [Related]
8. [Effect of the treatment with femoston on the cardiovascular system in postmenopausal women]. Kirichenko AA; Novichkova IuN Ter Arkh; 2001; 73(10):38-40. PubMed ID: 11763513 [TBL] [Abstract][Full Text] [Related]
9. Variations of cardiac performance and inotropism in healthy postmenopausal women treated with estroprogestin replacement therapy. Gallinelli A; Angioni S; Matteo ML; Montaldo PL; Fenu MA; Volpe A Menopause; 1999; 6(1):49-55. PubMed ID: 10100180 [TBL] [Abstract][Full Text] [Related]
10. Physiologic estradiol replacement therapy and cardiac structure and function in normal postmenopausal women: a randomized, double-blind, placebo-controlled, crossover trial. Snabes MC; Payne JP; Kopelen HA; Dunn JK; Young RL; Zoghbi WA Obstet Gynecol; 1997 Mar; 89(3):332-9. PubMed ID: 9052580 [TBL] [Abstract][Full Text] [Related]
11. Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy. Maffei S; Mercuri A; Prontera C; Zucchelli GC; Vassalle C Climacteric; 2006 Dec; 9(6):452-8. PubMed ID: 17085378 [TBL] [Abstract][Full Text] [Related]
12. Exercise as an alternative to oral estrogen for amelioration of endothelial dysfunction in postmenopausal women. Harvey PJ; Picton PE; Su WS; Morris BL; Notarius CF; Floras JS Am Heart J; 2005 Feb; 149(2):291-7. PubMed ID: 15846267 [TBL] [Abstract][Full Text] [Related]
13. Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study. Davis SR; Stuckey BG; Norman RJ; Papalia MA; Drillich A; Bell RJ Menopause; 2008; 15(6):1065-9. PubMed ID: 18806686 [TBL] [Abstract][Full Text] [Related]
14. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease. Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047 [TBL] [Abstract][Full Text] [Related]
15. [Changes of cardiac function and hemodynamics in peripartum period]. Li CS; Zhang H; Xu Z Zhonghua Fu Chan Ke Za Zhi; 1994 Feb; 29(2):91-3, 124. PubMed ID: 8033634 [TBL] [Abstract][Full Text] [Related]
16. Comparative cardiovascular effects of different progestins in menopause. Rosano GM; Fini M Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197 [TBL] [Abstract][Full Text] [Related]
17. [Changes of nitric oxide and endothelin plasma levels and effects of hormone replacement therapy in postmenopausal women]. Lai A; Zhang J; Ding L Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):222-4. PubMed ID: 11776165 [TBL] [Abstract][Full Text] [Related]
18. Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations. Whitcroft SI; Crook D; Marsh MS; Ellerington MC; Whitehead MI; Stevenson JC Obstet Gynecol; 1994 Aug; 84(2):222-6. PubMed ID: 8041534 [TBL] [Abstract][Full Text] [Related]
19. Endothelin levels decrease after oral and nonoral estrogen in postmenopausal women with increased cardiovascular risk factors. Wilcox JG; Hatch IE; Gentzschein E; Stanczyk FZ; Lobo RA Fertil Steril; 1997 Feb; 67(2):273-7. PubMed ID: 9022602 [TBL] [Abstract][Full Text] [Related]
20. Effects of hormone replacement therapy on insulin resistance and platelet function tests. Saraç F; Saydam G; Sahin F; Oztekin K; Saygili F; Tüzün M; Yilmaz C Med Princ Pract; 2009; 18(1):43-7. PubMed ID: 19060490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]